AI
RCKT icon

Atom Investors’s Rocket Pharmaceuticals RCKT Stock Holding History

Atom Investors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,480
Closed -$128K – 810
2025
Q4 		$128K Sell
36,480
-16,854
-32% -$57.7K 0.01% 518
2025
Q3 		$174K Buy
+53,334
New +$168K 0.01% 524
2024
Q2 		– Sell
-11,472
Closed -$309K – 642
2024
Q1 		$309K Sell
11,472
-19,499
-63% -$554K 0.04% 406
2023
Q4 		$928K Buy
+30,971
New +$684K 0.16% 195

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atom Investors's RCKT Position: Q1 2026 in Review

Atom Investors sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 36,480 shares — an estimated $128K sold.

Atom Investors first reported a position in RCKT in Q4 2023 and held it in 4 quarters. The position peaked at $928K in Q4 2023. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Atom Investors reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 36,480 Rocket Pharmaceuticals shares in Q1 2026, an estimated $128K.
  • Atom Investors first reported a position in Rocket Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Atom Investors's Rocket Pharmaceuticals position peaked at $928K in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.